These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 513287)

  • 1. [Chemotherapy of bile duct infections. VIII. Studies on biliary excretion of cefamandole (author's transl)].
    Tanimura H; Takenaka M; Hikasa Y; Hashino H; Rai F; Kataoka S; Sato T
    Jpn J Antibiot; 1979 Oct; 32(10):1049-55. PubMed ID: 513287
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental and clinical study of the biliary excretion of cefamandole (author's transl)].
    Brogard JM; Pinget M; Arnaud JP; Dorner M; Adloff M; Lavillaureix J
    Pathol Biol (Paris); 1981 Jan; 29(1):25-30. PubMed ID: 7010273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excretion of cefamandole in the bile.
    Lindahl F; Kjaer TB; Thomsen VF
    Scand J Infect Dis Suppl; 1980; suppl 25():58-9. PubMed ID: 6937953
    [No Abstract]   [Full Text] [Related]  

  • 4. Biliary concentrations of cefamandole and its use in biliary tract surgery.
    Levi JU; Livingstone AS; Martinez OV; Zeppa R; Malinin T; Hutson DG; Einhorn NC
    Scand J Infect Dis Suppl; 1980; suppl 25():55-7. PubMed ID: 6782654
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fundamental and clinical studies on cefamandole in the field of obstetrics and gynecology (author's transl)].
    Hirabayashi K; Okada E
    Jpn J Antibiot; 1980 Apr; 33(4):416-26. PubMed ID: 6997530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on cefoperazone treatment for bile duct infections (author's transl)].
    Hirayama T; Kikuchi K
    Jpn J Antibiot; 1981 Jun; 34(6):934-8. PubMed ID: 6457179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experiences with cefmetazole for peritonitis and biliary tract infections with special reference to excretion of cefmetazole into bile (author's transl)].
    Saito T; Yamada Y; Yokoyama S
    Jpn J Antibiot; 1979 Apr; 32(4):504-8. PubMed ID: 459081
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fundamental and clinical studies on cefamandole in pediatric treatment (author's transl)].
    Motohiro T; Sakata Y; Nishiyama T; Nakajima T; Imai H; Ishimoto K; Tominaga K; Yamashita F; Takeya S
    Jpn J Antibiot; 1979 Sep; 32(9):930-7. PubMed ID: 501920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fundamental and clinical studies of cefamandole sodium in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
    Jpn J Antibiot; 1979 Sep; 32(9):912-29. PubMed ID: 387994
    [No Abstract]   [Full Text] [Related]  

  • 10. Estimation of the biliary excretion of different cephalosporins utilizing retrograde cholangio-pancreatography (ERCP).
    Ohnhaus EE; Halter F; Lebek G
    Endoscopy; 1981 Jan; 13(1):31-2. PubMed ID: 7460866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficiency of cefamandole in the prophylaxis and the treatment of infections of the biliary tract (author's transl)].
    Blairon J; Paulet P; Yourassowski E; Limbosch JM
    Acta Gastroenterol Belg; 1979; 42(9-10):415-26. PubMed ID: 122041
    [No Abstract]   [Full Text] [Related]  

  • 12. Cefamandole bile levels in patients with hepatobiliary disease.
    Uwaydah M; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1087-9. PubMed ID: 7159070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diffusion of cefamandole into the prostatic tissue (author's transl)].
    Adam D; Hofstetter AG; Eisenberger F
    Med Klin; 1979 Feb; 74(7):235-8. PubMed ID: 84331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile.
    Ratzan KR; Baker HB; Lauredo I
    Antimicrob Agents Chemother; 1978 Jun; 13(6):985-7. PubMed ID: 677864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and clinical studies of a new cephalosporin: cefamandole nafate].
    Di Nola F; Eandi M; Capra E; Soranzo ML; Bosio G; Bramato C; Salassa B; Andrini L; Robecchi GA
    Minerva Med; 1980 May; 71(21):1515-24. PubMed ID: 7383410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the administration of doxycycline still indicated in bacterial infections of the gallbladder and the bile ducts?
    Moorthi K; Wiederholt K
    Eur J Clin Pharmacol; 1981; 20(1):35-8. PubMed ID: 7308270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction.
    Levi JU; Martinez OV; Malinin TI; Zeppa R; Livingstone A; Hutson D; Calhoun P
    Antimicrob Agents Chemother; 1984 Dec; 26(6):944-6. PubMed ID: 6524908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary levels of ceforanide.
    Kenady DE; Ram MD
    Antimicrob Agents Chemother; 1983 May; 23(5):706-9. PubMed ID: 6870219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory and clinical studies of cefamandole in pediatric infections (author's transl)].
    Kawamura M; Uozumi K; Maki T; Tauchi N; Takashima Y
    Jpn J Antibiot; 1980 Apr; 33(4):429-32. PubMed ID: 6997532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of cefamandole on urinary tract and genital organ infections (author's transl)].
    Doi S; Fujimoto A; Ito M; Sugimoto O; Tsujii K
    Jpn J Antibiot; 1980 Apr; 33(4):411-5. PubMed ID: 6997528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.